Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 10/20 | 0.72 |
| ▸ | TPMT | P51580 | 1/20 | 0.67 |
| ▸ | RXRA | P19793 | 2/20 | 0.64 |
| ▸ | RXRB | P28702 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | CNR1 | P21554 | 3/20 | 0.55 |
| ▸ | CNR2 | P34972 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11850424 | 0.86 | CNR1 (0.69) | SRD5A2TPMTTSHRALOX15CNR1 | |
| SCHEMBL9541835 | 0.84 | CNR2 (0.70) | SRD5A2TPMTRXRARXRBCNR1 | |
| Terephthalic Acid SCHEMBL11195049 | 0.84 | TPMT (0.76) | SRD5A2TPMTRXRARXRBTSHR | |
| SCHEMBL4028272 | 0.84 | SRD5A2 (1.00) | SRD5A2RXRARXRBTSHRALOX15 | |
| SCHEMBL4465360 | 0.83 | TPMT (0.65) | SRD5A2TPMTRXRARXRBTSHR | |
| SCHEMBL9360597 | 0.83 | MAPK1 (0.72) | SRD5A2TPMTCNR1CNR2HCAR1 | |
| SCHEMBL8437706 | 0.82 | SRD5A2 (0.64) | SRD5A2RXRARXRBTSHRALOX15 | |
| SCHEMBL28565971 | 0.81 | SRD5A2 (0.79) | SRD5A2TSHRALOX15TP53 | |
| SCHEMBL23699 | 0.81 | TPMT (1.00) | SRD5A2TPMTRXRARXRBTSHR | |
| SCHEMBL28214359 | 0.81 | TPMT (1.00) | SRD5A2TPMTRXRARXRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5998433-A | THERAPY FOR HYPERLIPIDEMIA; ATHEROSCLEROSIS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-12-07 | — | — | US | disclosed |
| CN-1160403-A | Substd. heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-09-24 | — | — | CN | disclosed |
| EP-0785939-A1 | SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS | Takeda Chemical Industries, Ltd. (JP) | 1997-07-30 | — | — | EP | disclosed |
| WO-1996011201-A1 | SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-04-18 | — | — | WO | disclosed |